Scalability and Sustainability of a Surgical Infection Prevention Program in Low-Income Environments.
Journal
JAMA surgery
ISSN: 2168-6262
Titre abrégé: JAMA Surg
Pays: United States
ID NLM: 101589553
Informations de publication
Date de publication:
29 Nov 2023
29 Nov 2023
Historique:
pmc-release:
29
11
2024
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
aheadofprint
Résumé
Surgical infections are a major cause of perioperative morbidity and mortality, particularly in low-resource settings. Clean Cut, a 6-month quality improvement program developed by the global nonprofit organization Lifebox, has demonstrated improvements in postoperative infectious complications. However, the pilot program required intense external programmatic and resource support. To examine the improvement in adherence to infection prevention and control standards and rates of postoperative infections in hospitals in the Clean Cut program after implementation strategies were updated and program execution was refined. This cohort study evaluated and refined the Clean Cut implementation strategy to enhance scalability based on a qualitative study of its pilot phase, including formalizing programmatic and educational materials, building an automated data entry and analysis platform, and reorganizing hospital-based team composition. Clean Cut was introduced from January 1, 2019, to February 28, 2022, in 7 Ethiopian hospitals that had not previously participated in the program. Prospective data initiated on arrival in the operating room were collected, and patients were followed up through hospital discharge and with 30-day follow-up telephone calls. Implementation of the refined Clean Cut program. The primary outcome was surgical site infection (SSI); secondary outcomes were adherence to 6 infection prevention standards, mortality, hospital length of stay, and other infectious complications. A total of 3364 patients (mean [SD] age, 26.5 [38.0] years; 2196 [65.3%] female) from 7 Ethiopian hospitals were studied (1575 at baseline and 1789 after intervention). After controlling for confounders, the relative risk of SSIs was reduced by 34.0% after program implementation (relative risk, 0.66; 95% CI, 0.54-0.81; P < .001). Appropriate Surgical Safety Checklist use increased from 16.3% to 43.0% (P < .001), surgeon hand and patient skin antisepsis improved from 46.0% to 66.0% (P < .001), and timely antibiotic administration improved from 17.8% to 39.0% (P < .001). Surgical instrument (38.7% vs 10.2%), linen sterility (35.5% vs 12.8%), and gauze counting (89.2% vs 82.5%; P < .001 for all comparisons) also improved significantly. A modified implementation strategy for the Clean Cut program focusing on reduced external resource and programmatic input from Lifebox, structured education and training materials, and wider hospital engagement resulted in outcomes that matched our pilot study, with improved adherence to recognized infection prevention standards resulting in a reduction in SSIs. The demonstration of scalability reinforces the value of this SSI prevention program.
Identifiants
pubmed: 38019510
pii: 2812301
doi: 10.1001/jamasurg.2023.6033
pmc: PMC10687710
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Surg Infect (Larchmt). 2018 Jan;19(1):25-32
pubmed: 29135348
Int J Qual Health Care. 2019 Apr 1;31(3):166-172
pubmed: 30020489
Health Inf Manag. 2019 May;48(2):62-75
pubmed: 29898604
Surg Infect (Larchmt). 2017 Oct;18(7):780-786
pubmed: 28832246
Surg Infect (Larchmt). 2018 Oct;19(7):684-690
pubmed: 30124378
JAMA Surg. 2017 Aug 01;152(8):784-791
pubmed: 28467526
Am J Surg. 2014 Nov;208(5):835-840
pubmed: 25113797
Ethiop J Health Sci. 2017 May;27(3):283-290
pubmed: 29217927
Int J Infect Dis. 2017 Apr;57:138-143
pubmed: 28216179
Glob Bioeth. 2018 Feb 26;29(1):39-54
pubmed: 29503603
Ann Surg. 2010 May;251(5):976-80
pubmed: 20395848
J Infect Public Health. 2015 May-Jun;8(3):298-301
pubmed: 25466596
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
BMC Health Serv Res. 2019 Aug 17;19(1):579
pubmed: 31419972
J Gastrointest Surg. 2017 Nov;21(11):1915-1930
pubmed: 28620749
JAMA Surg. 2022 Jan 1;157(1):68-70
pubmed: 34730799
Implement Sci. 2019 Jun 6;14(1):57
pubmed: 31171004
Surg Infect (Larchmt). 2020 Sep;21(7):592-598
pubmed: 32478641
Lancet. 2021 Nov 6;398(10312):1687-1699
pubmed: 34710362
Lancet Glob Health. 2019 Jun;7(6):e698-e700
pubmed: 31060971
Infect Control Hosp Epidemiol. 2019 Mar;40(3):287-300
pubmed: 30786946
Med Care. 2014 Feb;52(2 Suppl 1):S66-73
pubmed: 24430269
J Hosp Infect. 2013 Dec;85(4):257-67
pubmed: 24209885
Lancet. 2018 Apr 21;391(10130):1589-1598
pubmed: 29306587
PLoS One. 2019 May 1;14(5):e0215643
pubmed: 31042774
Surgery. 2015 Jul;158(1):66-77
pubmed: 25920911
BMJ Open. 2019 Jan 30;9(1):e022923
pubmed: 30705237
Lancet Glob Health. 2021 Jul;9(7):e899-e900
pubmed: 34143987
Int J Infect Dis. 2020 Nov;100:123-131
pubmed: 32712427
Surg Infect (Larchmt). 2018 Aug/Sep;19(6):593-602
pubmed: 30156997
Lancet Infect Dis. 2018 May;18(5):507-515
pubmed: 29519766
Lancet Infect Dis. 2018 May;18(5):516-525
pubmed: 29452941
Surg Infect (Larchmt). 2022 Mar;23(2):183-190
pubmed: 35076317
JAMA. 2023 Jan 17;329(3):244-252
pubmed: 36648463
Lancet. 2022 Nov 19;400(10365):1767-1776
pubmed: 36328045
J Am Coll Surg. 2004 Apr;198(4):626-32
pubmed: 15051016
Br J Surg. 2021 Jun 22;108(6):727-734
pubmed: 34157086
BMC Health Serv Res. 2020 Aug 25;20(1):790
pubmed: 32843033